Glutamine
GENERAL DESCRIPTION:
The most abundant amino acid in muscles and blood, glutamine provides fuel for various cells of the immune system and is a critical component in wound repair. The body can make glutamine, but may not make enough when the body is under stress. Glutamine is found naturally in beans, brewer’s yeast, brown rice, dairy products, eggs, fish, legumes, meat, nuts, seafood, seeds, soy, whey, and whole grains.
ROLE FOR ANTI-AGING:
Preliminary evidence suggests that glutamine might help prevent infections in people who are over-stressed and athletes who are overtrained - and thus immunosuppressed. Glutamine may also be useful as a nutritional supplement for people undergoing recovery from illness. Some scientists have also suggested that glutamine could be useful as a treatment for food allergies. This speculation is based on a theory called "leaky gut syndrome," where proteins leak through the wall of the digestive tract and enter the blood, causing allergic reactions. There is some evidence to support this theory as several studies have suggested that glutamine supplements might reduce leakage through the intestinal walls. Because of this glutamine supplements have been suggested for people with other digestive problems, such as irritable bowel syndrome, Crohn’s disease, and ulcerative colitis. However, there have also been trials that have found that glutamine supplements were of no benefit to these people. Glutamine may be of benefit to patients with HIV as it has been shown to increase levels of glutathione, which interferes with viral activation, as well as significantly increasing lean body mass. Based on glutamine’s role in muscle, the amino acid may be useful for athletes experiencing overtraining syndrome.
DEFICIENCY SYMPTOMS:
There are no known symptoms of glutamine deficiency.
THERAPEUTIC DAILY AMOUNT:
Doses range from 1.5 to 6g daily, divided into several separate doses. The majority of healthy people do not need to take supplementary glutamine.
MAXIMUM SAFE LEVEL:
Not established - glutamine is generally regarded as safe.SIDE EFFECTS/CONTRAINDICATIONS:
People who are hypersensitive to monosodium glutamate (MSG) should use glutamine with caution, as the body metabolises glutamine into glutamate. Individuals taking antiseizure medications, for example carbamazepine, phenobarbital, Dilantin (phenytoin), Mysoline (primidone), and valproic acid (Depakene), should only take supplementary glutamine under medical supervision. People with kidney or liver disease should consult their doctor before taking supplementary glutamine.
Health Headlines
upcoming Events
U.S. Events
congresses
fellowships
-
Aesthetic Medicine Module I
Las Vegas, NV | Dec. 9-10, 2009 -
Anti-Aging & Regenerative Medicine Modules I, II, III & IX
Las Vegas, NV | Dec. 10-12, 2009 -
Preventative Medicine, Nutrition & Sports Medicine Module I
Las Vegas, NV | Dec. 9-11, 2009 -
Fellowship in Preventative Medicine, Nutrition & Sports Medicine Module III
Las Vegas, NV | Dec. 11-12, 2009
symposium
-
Advanced Hormone Symposium
Chicago, IL | Oct. 8-10, 2010
VIDEO: Brain Age Workshop
Dr. Eric Braverman, Director of The Place for Achieving Total Health
(PATH Medical), Chairs the
Brain Age Workshop taking place Dec. 9, 2009.
Held in conjunction with the Winter Session of the 17th Annual World
Congress on Anti-Aging Medicine & Regenerative Biomedical Technologies.
The Brain Age Workshop features presentations on Brain Mind Assessment
via Neuropsychological Analysis, Movement Deficiency Syndrome,
Hormones and the Brain, Nootropic Drug Mechanisms, and Traumatic Brain
Injury. View this video to learn about Dr. Braverman’s brain-based
model of aging and age modulation.
International Events
- Mexico City | Jan. 15-17, 2010
- Milan | Mar. 18-20, 2010
- Kuala Lumpur | Apr. 29 - May 2, 2010
- Jakarta | May 2010 (pending)
- Bucharest | May 2010 (pending)
- Seoul | May 2010 (pending)
- Melbourne | Aug. 21-22, 2010
- Dubai | Oct. 26-27, 2010
- Bali | October 2010 (pending)
- Mainz-Frankfurt | Nov. 8-10, 2010
- Sao Paulo | Nov. 12-14, 2010
- Shanghai | November 2010 (pending)





